Celgene recently completed our acquisition of the research and office campus at 556 Morris Avenue in Summit, across town from our headquarters location at 86 Morris Avenue. This new location will allow us to concentrate our New Jersey operations at two sites in close proximity in Summit, further expanding our presence in the community that has been so supportive of our mission to serve patients with cancer and other serious diseases.

Summit is an ideal strategic location for Celgene, with a direct train line to New York City where many of our partners operate and a number of our employees live. The Summit community itself serves as home to many Celgene employees and the downtown area is a hub for shopping, dining and recreation. Summit, with its central location in the tri-state area, is also close to numerous important medical centers and renowned academic institutions, providing a large pool of talented potential employees.

Summit’s municipal government has been transparent and collaborative, providing a supportive environment for our company and employees to thrive.  Summit officials have been extremely helpful in all our interactions as we strive to be a good neighbor and active corporate citizen. In the acquisition of our new campus, which involved no economic development incentives, we once again saw how helpful Mayor Dickson, the Common Council and City Administration have been, focusing intently on the best interests of the entire Summit community.

Sign Up for E-News

We are proud of our long relationship with Summit and excited at the opportunity that our expanded presence in this great community provides for us to advance our mission of improving the lives of patients around the world.

Bob Hugin

Chairman and CEO, Celgene Corporation